These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35565875)

  • 1. Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.
    Shahid A; Lewis DM
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
    N Engl J Med; 2022 Sep; 387(10):869-881. PubMed ID: 36069869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).
    Melmer A; Züger T; Lewis DM; Leibrand S; Stettler C; Laimer M
    Diabetes Obes Metab; 2019 Oct; 21(10):2333-2337. PubMed ID: 31183929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes.
    Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M
    J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Glucose Forecasting for Open-Source Automated Insulin Delivery Systems: A Machine Learning Study with Real-World Variability Analysis.
    Zafar A; Lewis DM; Shahid A
    Healthcare (Basel); 2023 Mar; 11(6):. PubMed ID: 36981436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol.
    Lee TTM; Collett C; Man MS; Hammond M; Shepstone L; Hartnell S; Gurnell E; Byrne C; Scott EM; Lindsay RS; Morris D; Brackenridge A; Dover AR; Reynolds RM; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Bocchino LE; Sibayan J; Kollman C; Wilinska ME; Hovorka R; Murphy HR;
    BMC Pregnancy Childbirth; 2022 Apr; 22(1):282. PubMed ID: 35382796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
    Wilmot EG; Choudhary P; Leelarathna L; Baxter M
    Diabetes Obes Metab; 2019 Dec; 21(12):2599-2608. PubMed ID: 31364268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID.
    Lewis D
    J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life.
    Litchman ML; Lewis D; Kelly LA; Gee PM
    J Diabetes Sci Technol; 2019 Mar; 13(2):164-170. PubMed ID: 30198751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems.
    Toffanin C; Kozak M; Sumnik Z; Cobelli C; Petruzelkova L
    Diabetes Technol Ther; 2020 Feb; 22(2):112-120. PubMed ID: 31769699
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.